MOG and demyelinating disease: Furthermore, in a marmoset model of EAE, a tolerization procedure with MOG results in early protection from acute disease but the late onset of a lethal demyelinating disorder, associated with a Th2 shift of myelin-reactive T cells and increased titres of MOG-reactive autoantibodies [32].